SAMHD1 and neoplasm: Here, based on previous data pointing towards a prognostic role of SAMHD1 in BC [30], we describe the use of SAMHD1 expression in tumor biopsies post-surgery as a novel prognostic biomarker in early BC patients with residual disease after NACT, where there is still the need to develop effective biomarkers and more efficient alternative treatment options.